DOI: 10.1055/s-00037682

International Journal of Epilepsy

Referenz

Krauss GL, Perucca E, Ben-Menachem E. et al.
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase 3, extension study 307.

Epilepsia
54 January (1) 2013; 126-134

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: